In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves
- PMID: 28157718
- DOI: 10.1088/1748-605X/aa5644
In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves
Abstract
Notwithstanding their wide exploitation, biological prosthetic heart valves are characterized by limited durability (10-15 years). The treatment of biological tissues with chemical crosslinking agents such as glutaraldehyde accounts for the enhanced risk of structural deterioration associated with the early failure of bioprosthetic valves. To overcome the shortcomings of the currently available solutions, adoption of decellularized biological tissues of animal origin has emerged as a promising approach. The present study aims to assess in vitro cardiovascular scaffolds composed of bovine pericardium decellularized with the novel TRITDOC (TRIton-X100 and TauroDeOxyCholic acid) procedure. The effects of the treatment have been assessed by means of histological, biomolecular, cellular, biochemical and biomechanical analyses. The TRITDOC procedure grants the complete decellularization of bovine pericardial scaffolds while preserving the extracellular matrix architecture and the biomechanical properties. With a dedicated ELISA test, the TRITDOC procedure has been proven to ensure the complete removal of the alphaGal antigen, responsible for hyperacute rejection and for long-term deterioration of xenogenic biomaterials. Static seeding of the acellular pericardial patches with human adipose-derived stem cells resulted in an evenly repopulated scaffold without signs of calcification. The in vitro cyto-/immuno-compatibility response of the TRITDOC-bovine pericardium was compared with glutaraldehyde-treated xenogenic pericardium collected from two bioprosthetic devices currently used in clinical practice: PERIMOUNT MAGNA and TRIFECTATM. TRITDOC-bovine pericardium exhibited lower complement activation, lower cytotoxicity and a lower tendency to secrete pro-inflammatory cytokines compared to the tested commercial bioprostheses. Therefore, TRITDOC-decellularized pericardium could be considered as possible candidate material for the production of prosthetic heart valves.
Similar articles
-
Pericardial tissue for cardiovascular application: an in-vitro evaluation of established and advanced production processes.J Mater Sci Mater Med. 2018 Nov 3;29(11):172. doi: 10.1007/s10856-018-6186-6. J Mater Sci Mater Med. 2018. PMID: 30392024
-
Transplantation material bovine pericardium: biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing.Xenotransplantation. 2012 Sep-Oct;19(5):286-97. doi: 10.1111/j.1399-3089.2012.00719.x. Xenotransplantation. 2012. PMID: 22978462
-
Biomechanical characterization of decellularized and cross-linked bovine pericardium.J Heart Valve Dis. 2007 Mar;16(2):165-74. J Heart Valve Dis. 2007. PMID: 17484467
-
Decellularized tissue-engineered heart valves calcification: what do animal and clinical studies tell us?J Mater Sci Mater Med. 2020 Dec 5;31(12):132. doi: 10.1007/s10856-020-06462-x. J Mater Sci Mater Med. 2020. PMID: 33278023 Free PMC article. Review.
-
Mechanical testing of pericardium for manufacturing prosthetic heart valves.Interact Cardiovasc Thorac Surg. 2016 Jan;22(1):72-84. doi: 10.1093/icvts/ivv282. Epub 2015 Oct 21. Interact Cardiovasc Thorac Surg. 2016. PMID: 26489665 Review.
Cited by
-
Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications.Front Bioeng Biotechnol. 2022 Dec 12;10:1042434. doi: 10.3389/fbioe.2022.1042434. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36578513 Free PMC article.
-
Decellularized Bovine Skeletal Muscle Scaffolds: Structural Characterization and Preliminary Cytocompatibility Evaluation.Cells. 2024 Apr 16;13(8):688. doi: 10.3390/cells13080688. Cells. 2024. PMID: 38667303 Free PMC article.
-
Extracellular Matrix-Based Biomaterials and Their Influence Upon Cell Behavior.Ann Biomed Eng. 2020 Jul;48(7):2132-2153. doi: 10.1007/s10439-019-02408-9. Epub 2019 Nov 18. Ann Biomed Eng. 2020. PMID: 31741227 Free PMC article.
-
Pericardial tissue for cardiovascular application: an in-vitro evaluation of established and advanced production processes.J Mater Sci Mater Med. 2018 Nov 3;29(11):172. doi: 10.1007/s10856-018-6186-6. J Mater Sci Mater Med. 2018. PMID: 30392024
-
Natural Scaffolds for Regenerative Medicine: Direct Determination of Detergents Entrapped in Decellularized Heart Valves.Biomed Res Int. 2017;2017:9274135. doi: 10.1155/2017/9274135. Epub 2017 Jun 6. Biomed Res Int. 2017. PMID: 28676861 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources